RPS6KB1 and non-small cell lung carcinoma: Fu et al. have demonstrated the anticancer actions of HR in non-small cell lung cancer by inducing apoptosis and autophagy via inhibition of the AKT/mTOR/p70S6K signaling pathway [41].